CF
TMO icon

Covea Finance’s Thermo Fisher Scientific TMO Stock Holding History

Covea Finance’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$41.9M Sell
83,545
-14,640
-15% -$7.03M 1.32% 21
2026
Q1 		$48.3M Buy
98,185
+1,668
+2% +$905K 1.69% 11
2025
Q4 		$55.9M Hold
96,517
– – 1.84% 10
2025
Q3 		$46.8M Sell
96,517
-4,637
-5% -$2.16M 1.63% 15
2025
Q2 		$41M Sell
101,154
-1,960
-2% -$819K 1.52% 22
2025
Q1 		$51.3M Buy
103,114
+3,913
+4% +$2.12M 2.36% 10
2024
Q4 		$51.6M Sell
99,201
-5,410
-5% -$2.97M 2.33% 11
2024
Q3 		$64.7M Buy
104,611
+15,500
+17% +$9.18M 2.84% 6
2024
Q2 		$49.3M Buy
89,111
+4,300
+5% +$2.46M 2.26% 12
2024
Q1 		$49.3M Buy
84,811
+15,700
+23% +$8.81M 2.33% 11
2023
Q4 		$36.7M Buy
69,111
+4,500
+7% +$2.18M 1.79% 16
2023
Q3 		$32.7M Buy
64,611
+10,430
+19% +$5.56M 1.84% 15
2023
Q2 		$28.3M Sell
54,181
-20,033
-27% -$10.8M 1.54% 24
2023
Q1 		$42.8M Sell
74,214
-6,656
-8% -$3.75M 2.44% 5
2022
Q4 		$44.5M Sell
80,870
-2,550
-3% -$1.35M 2.22% 9
2022
Q3 		$42.3M Buy
+83,420
New +$46.7M 2.22% 8

Other funds holding TMO

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
LT
Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return
SP
Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
PL
Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return

Covea Finance's TMO Position: Q2 2026 in Review

Covea Finance reduced its Thermo Fisher Scientific (TMO) stake by 15% in Q2 2026, selling an estimated $7.03M and leaving 83,545 shares worth $41.9M. The position accounts for 1.32% of the portfolio, ranked #21.

Covea Finance first reported a position in TMO in Q3 2022 and has held it in 16 quarters since. The position peaked at $64.7M in Q3 2024. 429 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Covea Finance held 83,545 shares of Thermo Fisher Scientific worth $41.9M as of Q2 2026.
  • Covea Finance sold 14,640 Thermo Fisher Scientific shares in Q2 2026, an estimated $7.03M.
  • Thermo Fisher Scientific made up 1.32% of Covea Finance's portfolio in Q2 2026, its #21 holding.
  • Covea Finance first reported a position in Thermo Fisher Scientific in Q3 2022 and has held it in 16 quarters since.
  • Covea Finance's Thermo Fisher Scientific position peaked at $64.7M in Q3 2024.
  • 429 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Covea Finance's 13F filing for Q2 2026, filed 13 Jul 2026.